Early-Stage Venture Funding

Health Care

FinTech

Software
Technology

Consumer Products

Founded in 2003, Shamrock Capital Partners utilizes a disciplined approach to seek companies with the right fit for venture capital and Series A funding. We concentrate on working with technology-based startups and providing patient equity.

SCP founder Ray Lopez will partner with companies independently, as part of the investment group Irish Angels Network, and as an investor in Vitalize Venture Capital. Our focus lies mostly in early-stage U.S. companies in health care, software, technology, and consumer products.

Investment Capital + Expertise & Integrity

Shamrock Capital Partners is a closely held, private equity group that acquires, manages, and builds companies in partnership with existing management.

More than just investment capital, you can harness our expertise and integrity to move your business forward. By partnering with management groups on results-oriented strategic planning, operations improvement, and sales and marketing strategies, we’re able to help companies reach their next level of success.

Who We Invest In

As you’ve done your research in seeking out investment firms, we also perform our due diligence in considering investment opportunities. Whether we decide to invest directly with you or through one of our partner networks, we look for the following positive attributes and indicator criteria.

What We Look for in Investment Opportunities

Startups raising pre-seed or seed round of $1‒$3M
Term sheet has been issued from a lead investor
Pre-money valuations no greater than $12M
A potential 30x CoC return for investors
Highly scalable software solution
Initial indications of product-market fit (e.g., early revenues or customer acquisition)
Strong growth potential
Former entrepreneurial or directly relevant industry experience
A corporation located in the United States
Strong management team
Proven track record
Market leaders and industry leaders
Diverse customer base, with no customer representing more than 20% of sales